Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.40    -0.10 (-0.15%)
Bid:
64.40
Ask:
65.80
Spread: 1.40 (2.174%)
Market Cap: £110.71m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Half-year Report

11 Sep 2025 07:00

RNS Number : 8633Y
GCP Asset Backed Income Fund Ltd
11 September 2025
Β 

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815

Β 

Half-yearly report and unaudited interim condensed financialΒ statements

for the period ended 30 June 2025

Β 

11 September 2025

GCP Asset Backed, which invests in asset backed loans, is pleased to announce the publication of its half-yearly report and unaudited interim condensed financial statements for the period ended 30 June 2025 ("Interim Financial Statements") which are now available on the Company website at:Β Gravis | Literature (graviscapital.com).

Β 

Highlights for the period include:

Β 

Β· Dividends of 3.161 pence per share declared and paid for the period. Aggregate dividend payments over the last twelve months represent a 9.7% yield on the Company's closing share price at 30 June 2025.

Β 

Β· Strong progress has been made on the Company's managed wind-down. A total of 210.0 million shares have been redeemed since inception of the realisation programme, returning Β£188.2 million to shareholders and representing 67.4% of the Company's market capitalisation at 31 December 2023.

Β 

Β· Total NAV return2 for the period of 1.4% (30 June 2024: 1.0%) and total NAV return3 since IPO of 48.1%.

Β 

Β· Profit for the period of Β£2.5 million (30 June 2024: Β£1.7 million) reflecting continued progress against the realisation plan. Further information on financial performance is included on page 17 of the Interim Financial Statements.

Β 

Β· NAV per share of 79.793 pence at 30 June 2025, a decrease from the year end. Further information is included in the Investment Manager's report on pages 8 to 15 of the Interim Financial Statements.

Β 

Β· Repayments of Β£12.0 million received in the period. Interest amounts of Β£1.0 million were capitalised in accordance with contractual terms.

Β 

Β· Exposure to a diversified, partially inflation and/or interest rate protected portfolio of 23 asset backed loans with a third-party valuation of Β£153.6 million4 at 30 June 2025.

Β 

Β· Post period end, the Group received repayments totalling Β£2.4 million, including the repayment of one problem loan repaid in line with the fair valuation at 30 June 2025.

Β 

Β 

On the release of the Interim Financial Statements,Β Alex Ohlsson, Chairman of GCP Asset Backed, commented:

Β 

"The Company remains focused on the managed realisation of its assets and return of capital to shareholders. Since the inception of the realisation programme, the Company has returned Β£188.2 million to shareholders through the compulsory redemption of 210.0 million shares. In addition, the Company has maintained the payment of regular and stable dividends, with a further Β£6.8 million paid in the half yearly period, representing 3.161 pence per share.

Β 

It is the Board's intention to maintain the Company's existing level of dividend of 6.325 pence per ordinary share per annum5whilst the Company remains substantially invested, for as long as is practicable.

Β 

On behalf of the Board, I would like to thank our shareholders for their continued support."

Β 

Β 

1. Total dividends of 3.1625 pence per share includes a quarterly dividend of 1.58125 pence per share for the quarter to 30 June 2025, which was declared post period end.

2. Alternative performance measure - refer to pages 44 and 45 of the Interim Financial Statements for definitions and calculation methodology.

3. Does not include a provision for the dividend in respect of the quarter to 30 June 2025, which was declared and paid post period end.

4. Valuation of the loan portfolio held by the Subsidiary. The Company makes its investments through its wholly owned Subsidiary. Refer to note 1 for further information.

5. This is a target only and does not constitute a profit forecast.

Β 

Β 

For further information, please contact:

Gravis Capital Management Ltd

+44 (0)20 3405 8500

Philip Kent

Cameron Gardner

Anthony Curl

Β 

Β 

Barclays Bank plc

+44 (0)20 7623 2323

Dion Di Miceli

Stuart Muress

James Atkinson

Β 

Burson Buchanan

+44 (0)20 7466 5000

Helen Tarbet

Henry Wilson

Nick Croysdill

Β 

Notes to editors

Β 

GCP Asset Backed Income Fund Limited is a closed-ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

Β 

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset back loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR BRGDCGUBDGUG
Date   Source Headline
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020
23rd Jul 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:38 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSNet Asset Value and Investment Update
10th Jul 20207:00 amRNSExtension to term of Revolving Credit Facility
7th Jul 20204:22 pmRNSResult of AGM & EGM
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
26th May 20207:00 amRNSTransaction in Own Shares
22nd May 20207:00 amRNSTransaction in Own Shares
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:37 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNotices of AGM & EGM
4th May 20207:00 amRNSInvestor Report as at 31 March 2020
29th Apr 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
21st Apr 20207:00 amRNSNet Asset Value and Investment Update
7th Apr 20207:00 amRNSAnnual Report & AGM
31st Mar 20207:00 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSAnnual Report & Financial Statements
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSCompliance with Market Abuse Regulation
28th Feb 20209:47 amRNSTotal Voting Rights & Additional Listing
21st Feb 20207:00 amRNSAdditional Listing
17th Feb 20207:00 amRNSInvestment in co-living
6th Feb 20207:00 amRNSScrip Share Reference Price
30th Jan 20207:00 amRNSInvestor report as at 31 December 2019
29th Jan 20207:00 amRNSChange of corporate adviser
22nd Jan 20207:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jan 20207:00 amRNSNet Asset Value
16th Jan 20207:00 amRNSRevolving Credit Facility
29th Nov 20199:34 amRNSTotal Voting Rights and Additional Listing
25th Nov 20197:00 amRNSAdditional Listing
7th Nov 201910:08 amRNSScrip Share Reference Price
7th Nov 20197:00 amRNSDirectorate Change
31st Oct 20197:00 amRNSInvestor Report as at 30 September 2019
23rd Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 20197:00 amRNSSpecial dividend declaration
15th Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:00 amRNSTotal Voting Rights
10th Sep 20197:00 amRNSHalf-Yearly Report & Financial Statements
2nd Sep 201910:01 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20197:00 amRNSAdditional Listing
8th Aug 20197:00 amRNSScrip Share Reference Price
2nd Aug 20197:00 amRNSInvestor Report as at 30 June 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.